Ibandronate Sodium Tablets

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
SPE2D2-25-R-0019
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical is soliciting proposals for Ibandronate Sodium 150mg Tablets through solicitation SPE2D2-25-R-0019, seeking to establish a national pharmaceutical contract to supply the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. This procurement requires FDA current Good Manufacturing Practice (cGMP) compliance, therapeutic equivalence standards, and comprehensive documentation of manufacturing facilities from qualified pharmaceutical manufacturers. The contract will be awarded using the lowest price technically acceptable (LPTA) evaluation criteria through the Pharmaceutical Prime Vendor (PPV) program. Offerors must submit their proposals electronically through the Defense Logistics Agency Internet Bid Board System (DIBBS), with the submission deadline extended multiple times through amendments and currently set for October 10, 2025, at 3:00 PM EST. Key submission requirements include pricing information, trade agreements certification, subcontracting plans for large businesses, past performance documentation, and detailed manufacturing and product registration information.

This solicitation does not utilize any set-aside designations and will involve distribution through multiple established prime vendors including AmerisourceBergen, Cardinal Health, Dakota Drug, DMS Pharmaceutical Group, and McKesson Corp. The contract structure spans a five-year period consisting of one base year and four option years, with an annual requirement of 27,881 three-count blister packs of the medication. All contractors will be subject to a 0.5% cost recovery fee on sales and must submit quarterly sales reports to the government. While specific award values are not disclosed in the available documentation, the multi-year pharmaceutical supply contract represents a significant opportunity given the substantial annual quantities and extended performance period. Performance will occur nationally through the established pharmaceutical distribution network to serve military, veterans, and federal healthcare facilities across the United States.

Notice text

SPE2D2-25-R-0019 Ibandronate Sodium Tablets

Files

Notice history

Notice Type Posted
Ibandronate Sodium Tablets Award Award Notice
This notice Latest solicitation Solicitation
Ibandronate Sodium Tablets Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside
Epinephrine Injector NAICS 325412 Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity